文献速递免疫规划卫生政策与健康促进

基层医生对成人呼吸道合胞病毒疾病及疫苗的看法

Primary care physicians' perspectives on respiratory syncytial virus (RSV) disease in adults and a potential RSV vaccine for adults.
PubMed 文献 · Vaccine · 2018-12-28

2017年2-3月对美国930名诊治成人的基层医生进行网络和邮寄调查,回复率67%(620/930)。在接诊RSV患者的317人中,73%认为≥50岁患者流感通常比RSV更严重,57%很少考虑RSV为潜在病原体,61%因无治疗而不检测RSV;最常见疫苗障碍是患者自付费用(93%)和缺乏接种报销(74%)。

要点

  • 基层医生对成人RSV疾病经验不足,多数不检测且认为流感更严重。
  • 93%医生担忧疫苗无保险覆盖时患者自付费用,74%担忧缺乏接种报销。
  • 需加强成人RSV疾病负担及疫苗需求的信息教育。

核心结论

  • 基层医生对成人RSV疾病经验少,一般不检测,多数认为流感更严重,需更多疾病负担和疫苗需求信息。

研究设计与样本

  • 2017年2-3月对美国930名诊治成人的基层医生进行网络和邮寄调查,回复率67%(620/930)。

主要发现

  • 在接诊RSV患者的317人中,73%认为≥50岁患者流感通常比RSV更严重。
  • 57%很少考虑RSV为潜在病原体。
  • 61%因无治疗而不检测RSV。
  • 最常见疫苗障碍是患者自付费用(93%)和缺乏接种报销(74%)。

临床怎么用

  • 基层医生应提高对成人RSV疾病负担的认识,考虑在≥50岁患者中检测RSV。
  • 推动RSV疫苗纳入保险覆盖和接种报销以减少实施障碍。

局限性

  • 调查时间为2017年,RSV疫苗尚未上市,结果可能随疫苗进展变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Deaths attributable to respiratory syncytial virus (RSV) among adults are estimated to exceed 11,000 annually, and annual adult hospitalizations for influenza and RSV may be comparable. RSV vaccines for older adults are in development. We assessed the following among primary care physicians (PCPs) who treat adults: (1) perception of RSV disease burden; (2) current RSV testing practices; and (3) anticipated barriers to adoption of an RSV vaccine. METHODS: We administered an Internet and mail survey from February to March 2017 to national networks of 930 PCPs. RESULTS: The response rate was 67% (620/930). Forty-nine percent of respondents (n = 303) were excluded from analysis as they reported never or rarely caring for an adult patient with possible RSV in the past year. Among respondents who reported taking care of RSV patients (n = 317), 73% and 57% responded that in patients ≥ 50 years, influenza is generally more severe than RSV and that they rarely consider RSV as a potential pathogen, respectively. Most (61%) agreed that they do not test for RSV because there is no treatment. The most commonly reported anticipated barriers to a RSV vaccine were potential out-of-pocket expenses for patients if the vaccine is not covered by insurance (93%) and lack of reimbursement for vaccination (74%). CONCLUSIONS: Physicians reported little experience with RSV disease in adults. They are generally not testing for it and the majority believe that influenza disease is more severe. Physicians will require more information about RSV disease burden in adults and the potential need for a vaccine in their adult patients.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hurley LP, Allison MA, Kim L, et al. Primary care physicians' perspectives on respiratory syncytial virus (RSV) disease in adults and a potential RSV vaccine for adults. Vaccine. 2018. PMID: 30598385. doi:10.1016/j.vaccine.2018.12.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。